PPFIA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.126000E-01
Normal-vs-Stage2
4.284200E-01
Normal-vs-Stage3
5.393800E-01
Normal-vs-Stage4
5.732800E-01
Stage1-vs-Stage2
7.442000E-01
Stage1-vs-Stage3
1.758760E-01
Stage1-vs-Stage4
9.658600E-01
Stage2-vs-Stage3
9.056100E-02
Stage2-vs-Stage4
8.222800E-01
Stage3-vs-Stage4
3.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.604000E-01
Normal-vs-AfricanAmerican
4.326000E-01
Normal-vs-Asian
8.859400E-01
Caucasian-vs-AfricanAmerican
5.708400E-01
Caucasian-vs-Asian
2.833800E-01
AfricanAmerican-vs-Asian
3.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.898200E-01
Normal-vs-Female
4.310600E-01
Male-vs-Female
8.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.908200E-01
Normal-vs-Age(41-60Yrs)
9.327900E-02
Normal-vs-Age(61-80Yrs)
6.646800E-01
Normal-vs-Age(81-100Yrs)
5.928200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.306000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.995400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.257400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.121100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.404100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.705200E-01
Normal-vs-Daily Drinker
7.282800E-01
Normal-vs-Weekly Drinker
4.443600E-01
Normal-vs-Occasional Drinker
2.408400E-01
Normal-vs-Social Drinker
1.221820E-01
Non Drinker-vs-Daily Drinker
8.303800E-01
Non Drinker-vs-Weekly Drinker
2.048000E-01
Non Drinker-vs-Occasional Drinker
3.871500E-02
Non Drinker-vs-Social Drinker
8.382500E-02
Daily Drinker-vs-Weekly Drinker
2.628000E-01
Daily Drinker-vs-Occasional Drinker
1.008770E-01
Daily Drinker-vs-Social Drinker
1.856800E-01
Weekly Drinker-vs-Occasional Drinker
9.618600E-01
Weekly Drinker-vs-Social Drinker
7.092000E-01
Occasional Drinker-vs-Social Drinker
5.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.662440E-01
Normal-vs-Grade 2
4.630000E-01
Normal-vs-Grade 3
2.066000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.416770E-01
Grade 1-vs-Grade 3
3.351500E-02
Grade 1-vs-Grade 4
1.662440E-01
Grade 2-vs-Grade 3
2.084400E-01
Grade 2-vs-Grade 4
4.630000E-01
Grade 3-vs-Grade 4
2.066000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.288200E-01
Normal-vs-NonDiabetic
4.037800E-01
Diabetic-vs-NonDiabetic
4.512100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.518100E-02
Normal-vs-NoPancreatitis
5.745000E-01
Pancreatitis-vs-NoPancreatitis
1.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.984800E-01
Normal-vs-N1
4.302400E-01
N0-vs-N1
4.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.333600E-01
Normal-vs-TP53-NonMutant
8.947000E-01
TP53-Mutant-vs-TP53-NonMutant
6.559600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
